Literature DB >> 7886775

Multiresistant falciparum malaria cured using atovaquone and proguanil.

T J Blanchard1, D C Mabey, A Hunt-Cooke, G Edwards, D B Hutchinson, S Benjamin, P L Chiodini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7886775     DOI： 10.1016/0035-9203(94)90233-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  5 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Cerebral malaria in spite of peripheral parasite clearance in a patient treated with atovaquone/proguanil.

Authors:  Stefanie Koch; Klaus Göbels; Joachim Richter; Mark Oette; Dieter Häussinger
Journal:  Parasitol Res       Date:  2006-09-27       Impact factor: 2.289

Review 3.  Atovaquone-proguanil for treating uncomplicated malaria.

Authors:  A Osei-Akoto; L Orton; S P O Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

4.  Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance.

Authors:  S Gassis; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

5.  Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.

Authors:  Tina S Skinner-Adams; John H Ryan; Katherine T Andrews; Gillian M Fisher; Andrew G Riches; Oliver E Hutt; Karen E Jarvis; Tony Wilson; Mark von Itzstein; Pradeep Chopra; Yevgeniya Antonova-Koch; Stephan Meister; Elizabeth A Winzeler; Mary Clarke; David A Fidock; Jeremy N Burrows
Journal:  Commun Biol       Date:  2019-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.